The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Compare index funds with the lowest expense ratios for retirement in 2024 to minimize fees while pursuing solid returns. Find your top pick today.
27,341 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Binance’s reported mesh investment could shift who controls stablecoin payment rails, signaling a shift from issuers ...
A sharp 20% plunge in Circle tokens sparked by yield shifts under a new Clarity Act framework. This morning minute re...
Legendary investor Michael Burry has taken a direct short against Micron Technology, challenging the view that AI-dri...
In a sign of a sustained unwind, the bhutan government moves another tranche of BTC as 2026 outflows surge. Arkham re...
Palantir’s CEO has shifted away from traditional earnings calls, instead sending quarterly shareholder letters that m...
A Senate committee greenlit the CLARITY Act in a 15-9 vote, sending the bill to the full chamber. Markets jumped as X...
Oil-driven energy costs and geopolitical risk push mortgage rates up, complicating plans for would-be homeowners as t...
Intuitive Machines has shown dramatic price swings, with intraday surges followed by swift pullbacks. This article ex...
As the EV market accelerates, investors face a key question: which stock—Rivian or Tesla—fits their risk tolerance an...
Travel stocks rarely move in perfect tandem. This guide weighs Booking Holdings and Marriott International to help yo...
Five AI hyperscalers are funding a global data-center boom with bonds, signaling a trillion-dollar shift in how Big T...